| First Author | Durnin L | Year | 2017 |
| Journal | Am J Physiol Gastrointest Liver Physiol | Volume | 313 |
| Issue | 5 | Pages | G419-G433 |
| PubMed ID | 28705804 | Mgi Jnum | J:253737 |
| Mgi Id | MGI:6101305 | Doi | 10.1152/ajpgi.00045.2017 |
| Citation | Durnin L, et al. (2017) Loss of nitric oxide-mediated inhibition of purine neurotransmitter release in the colon in the absence of interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol 313(5):G419-G433 |
| abstractText | Regulation of colonic motility depends on the integrity of enteric inhibitory neurotransmission mediated by nitric oxide (NO), purine neurotransmitters, and neuropeptides. Intramuscular interstitial cells of Cajal (ICC-IM) and platelet-derived growth factor receptor-alpha-positive (PDGFRalpha(+)) cells are involved in generating responses to NO and purine neurotransmitters, respectively. Previous studies have suggested a decreased nitrergic and increased purinergic neurotransmission in Kit(W)/Kit(W-v) (W/W(v) ) mice that display lesions in ICC-IM along the gastrointestinal tract. However, contributions of NO to these phenotypes have not been evaluated. We used small-chamber superfusion assays and HPLC to measure the spontaneous and electrical field stimulation (EFS)-evoked release of nicotinamide adenine dinucleotide (NAD(+))/ADP-ribose, uridine adenosine tetraphosphate (Up4A), adenosine 5''-triphosphate (ATP), and metabolites from the tunica muscularis of human, monkey, and murine colons and circular muscle of monkey colon, and we tested drugs that modulate NO levels or blocked NO receptors. NO inhibited EFS-evoked release of purines in the colon via presynaptic neuromodulation. Colons from W/W(v), Nos1(-/-) , and Prkg1(-/-) mice displayed augmented neural release of purines that was likely due to altered nitrergic neuromodulation. Colons from W/W(v) mice demonstrated decreased nitrergic and increased purinergic relaxations in response to nerve stimulation. W/W(v) mouse colons demonstrated reduced Nos1 expression and reduced NO release. Our results suggest that enhanced purinergic neurotransmission may compensate for the loss of nitrergic neurotransmission in muscles with partial loss of ICC. The interactions between nitrergic and purinergic neurotransmission in the colon provide novel insight into the role of neurotransmitters and effector cells in the neural regulation of gastrointestinal motility.NEW & NOTEWORTHY This is the first study investigating the role of nitric oxide (NO) and intramuscular interstitial cells of Cajal (ICC-IM) in modulating neural release of purines in colon. We found that NO inhibited release of purines in human, monkey, and murine colons and that colons from Kit(W)/Kit(W-v) (W/W(v) ) mice, which present with partial loss of ICC-IM, demonstrated augmented neural release of purines. Interactions between nitrergic and purinergic neurotransmission may affect motility in disease conditions with ICC-IM deficiencies. |
